c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven — New Haven, Connecticut

c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven has participated in 1 clinical trials.

Therapeutic areas: CD33 Positive Acute Myelogenous Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven?

c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven conducted?

c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven has 1 clinical trials on record. Their work covers CD33 Positive Acute Myelogenous Leukemia.

Is c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven accredited by Crixeo Health?

c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.